These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31453917)

  • 1. Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting.
    Hamedani AG; Pistilli M; Singhal S; Shindler KS; Avery RA; Tamhankar MA; Liu GT
    J Neuroophthalmol; 2020 Mar; 40(1):8-14. PubMed ID: 31453917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJGM; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Silvestri NJ; Conwit R; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    Lancet Neurol; 2019 Mar; 18(3):259-268. PubMed ID: 30692052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate.
    Li F; Li Z; Chen Y; Bauer G; Uluk D; Elsner A; Swierzy M; Ismail M; Meisel A; Rückert JC
    Eur J Cardiothorac Surg; 2020 Mar; 57(3):478-487. PubMed ID: 31628812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
    Clifford KM; Hobson-Webb LD; Benatar M; Burns TM; Barnett C; Silvestri NJ; Howard JF; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; Laboy SM; Fellman MA; Howard DB; Kolb NA; Greene SM; Pasnoor M; Dimachkie MM; Barohn RJ; Hehir MK
    Muscle Nerve; 2019 Apr; 59(4):404-410. PubMed ID: 30575980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis.
    Zhang J; Zhang Z; Zhang H; Cui Y; Chen Y; Lv P; Zhang P
    Orphanet J Rare Dis; 2022 Aug; 17(1):309. PubMed ID: 35945595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.
    Olanow CW; Wechsler AS; Roses AD
    Ann Surg; 1982 Aug; 196(2):113-21. PubMed ID: 7092360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
    Li H; Ruan Z; Gao F; Zhou H; Guo R; Sun C; Xu Q; Lu Q; Zhou Y; Zhao Z; Yu L; Wu S; Lei T; Gao T; Tang Y; Li C; Huo F; Zhu Y; Sun J; Tang B; Zhang M; Gao Y; Lu X; Li Z; Chang T
    Neurotherapeutics; 2021 Oct; 18(4):2449-2457. PubMed ID: 34625864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after robotic thymectomy for nonthymomatous myasthenia gravis.
    Freeman RK; Ascioti AJ; Van Woerkom JM; Vyverberg A; Robison RJ
    Ann Thorac Surg; 2011 Sep; 92(3):1018-22; discussion 1022-3. PubMed ID: 21871293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Robotic Thymectomy Performed in Myasthenia Gravis Patients Older Than 60 Years at Onset.
    Li F; Takahashi R; Bauer G; Yousef MS; Hotter B; Swierzy M; McAleenan A; Ismail M; Meisel A; Rueckert JC
    Ann Thorac Surg; 2019 Sep; 108(3):912-919. PubMed ID: 30885848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors].
    Deng Y; Zhang X
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1922-5. PubMed ID: 19953918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: a study from India.
    Singhal BS; Bhatia NS; Umesh T; Menon S
    Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.
    Kostera-Pruszczyk A; Kwiecinski H
    J Neurol; 2009 Oct; 256(10):1780-1. PubMed ID: 19548060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
    Yang J; Liu C; Li T; Li C
    Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seronegative myasthenia gravis: disease severity and prognosis.
    Romi F; Aarli JA; Gilhus NE
    Eur J Neurol; 2005 Jun; 12(6):413-8. PubMed ID: 15885043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients.
    Guillermo GR; Téllez-Zenteno JF; Weder-Cisneros N; Mimenza A; Estañol B; Remes-Troche JM; Cantu-Brito C
    Acta Neurol Scand; 2004 Mar; 109(3):217-21. PubMed ID: 14763961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.